Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60,026,563
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
4,372,667
-
Shares change
-
-55,088
-
Total reported value, excl. options
-
$18,317,243
-
Value change
-
-$231,292
-
Number of buys
-
10
-
Number of sells
-
-5
-
Price
-
$4.19
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q1 2016
26 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2016.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,372,667 shares
of 60,026,563 outstanding shares and own 7.28% of the company stock.
Largest 10 shareholders include FMR LLC (1,437,811 shares), PERCEPTIVE ADVISORS LLC (1,240,458 shares), DEERFIELD MANAGEMENT CO (471,259 shares), SPHERA FUNDS MANAGEMENT LTD. (238,500 shares), DAFNA Capital Management LLC (176,232 shares), BAKER BROS. ADVISORS LP (142,000 shares), Knoll Capital Management, LP (135,800 shares), VANGUARD GROUP INC (121,407 shares), MILLENNIUM MANAGEMENT LLC (100,045 shares), and Weiss Multi-Strategy Advisers LLC (71,172 shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.